New studies show that inflammatory markers and blood cells may be related to epithelial
ovarian cancer (EOC). We aimed to examine whether mean platelet volume would be a …

Aim: Increasing evidence indicates that platelet count is a useful biomarker of long-term
outcomes in patients with ovarian cancer. However, the prognostic value of platelet count in …

Objective: Evaluation of mean platelet volume (MPV), neutrophil to lymphocyte ratio (NLR),
and platelet count in the detection of malignant and benign ovarian tumors. Material and …

The platelet lymphocyte ratio (PLR) is an important prognostic biomarker in various cancers.
The current retrospective study was undertaken to determine the association between PLR …

Background Cancer is widely believed to result from chronic inflammation, and red cell
distribution width (RDW) and mean platelet volume (MPV) are considered as inflammatory …

Background Platelet-to-lymphocyte (PLR) and Neutrophil-to-Lymphocyte (NLR) ratios have
been extensively investigated in cancer. However, to date, actual guidelines concerning …

Aim The aim of this study is to investigate the impact of preoperative platelet counts,
parameters and aggregation rates (maximal aggregation rate: MAR) on prognosis in …

Objective To determine whether preoperative platelets to lymphocyte ratio (PLR) could
predict disease stage, surgical outcome, and survival in patients with epithelial ovarian …

The aim of the present study was to determine the most meaningful preoperative prognostic
factor of cancer-related death in ovarian cancer patients by comparing potentially prognostic …

Objectives We sought to determine the impact of pretreatment plasma platelet levels,
dimerized plasmin fragment (D-dimer) and fibrinogen in recurrent epithelial ovarian cancer …